Michael P. Mohning

Michael P. Mohning

Auto-generated profile, based on publicly available information

Michael P. Mohning

Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health, J229, 1400 Jackson Street, Denver, CO 80206, USA; Division of Pulmonary and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
KMKara J. Mould
Kara J. Mould
LBLea Barthel
Lea Barthel
MMMichael P. Mohning
Michael P. Mohning
STStacey M. Thomas
Stacey M. Thomas
AMAlexandra L. McCubbrey
Alexandra L. McCubbrey
WJWilliam J. Janssen
William J. Janssen
Two populations of alveolar macrophages (AMs) coexist in the inflamed lung: resident AMs that arise during embryogenesis, and recruited AMs that originate postnatally from circulating monocytes. The objective of this study was to determine whether origin or environment dictates the transcriptional, metabolic, and functional programming of these two ontologically distinct populations over the time course of acute inflammation. RNA sequencing demonstrated marked transcriptional differences between resident and recruited AMs affecting three main areas: proliferation, inflammatory signaling, and metabolism. Functional assays and metabolomic studies confirmed these differences and demonstrated that resident AMs proliferate locally and are governed by increased tricarboxylic acid cycle and amino acid metabolism. Conversely, recruited AMs produce inflammatory cytokines in association with increased glycolytic and arginine metabolism. Collectively, the data show that even though they coexist in the same environment, inflammatory macrophage subsets have distinct immunometabolic programs and perform specialized functions during inflammation that are associated with their cellular origin.

26 October 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
VGVamsi P. Guntur
Vamsi P. Guntur
TNTravis Nemkov
Travis Nemkov
EBEsther de Boer
Esther de Boer
MMMichael P. Mohning
Michael P. Mohning
DBDavid Baraghoshi
David Baraghoshi
Angelo D'AlessandroAngelo D'Alessandro
Angelo D'Alessandro
Exercise intolerance is a major manifestation of post-acute sequelae of severe acute respiratory syndrome coronavirus infection (PASC, or “long-COVID”). Exercise intolerance in PASC is associated with higher arterial blood lactate accumulation and lower fatty acid oxidation rates during graded exercise tests to volitional exertion, suggesting altered metabolism and mitochondrial dysfunction. It remains unclear whether the profound disturbances in metabolism that have been identified in plasma from patients suffering from acute coronavirus disease 2019 (COVID-19) are also present in PASC. To bridge this gap, individuals with a history of previous acute COVID-19 infection that did not require hospitalization were enrolled at National Jewish Health (Denver, CO, USA) and were grouped into those that developed PASC (n = 29) and those that fully recovered (n = 16). Plasma samples from the two groups were analyzed via mass spectrometry-based untargeted metabolomics and compared against plasma metabolic profiles of healthy control individuals (n = 30). Observational demographic and clinical data were retrospectively abstracted from the medical record. Compared to plasma of healthy controls or individuals who recovered from COVID-19, PASC plasma exhibited significantly higher free- and carnitine-conjugated mono-, poly-, and highly unsaturated fatty acids, accompanied by markedly lower levels of mono-, di- and tricarboxylates (pyruvate, lactate, citrate, succinate, and malate), polyamines (spermine) and taurine. Plasma from individuals who fully recovered from COVID-19 exhibited an intermediary metabolic phenotype, with milder disturbances in fatty acid metabolism and higher levels of spermine and taurine. Of note, depletion of tryptophan—a hallmark of disease severity in COVID-19—is not normalized in PASC patients, despite normalization of kynurenine levels—a tryptophan metabolite that predicts mortality in hospitalized COVID-19 patients. In conclusion, PASC plasma metabolites are indicative of altered fatty acid metabolism and dysfunctional mitochondria-dependent lipid catabolism. These metabolic profiles obtained at rest are consistent with previously reported mitochondrial dysfunction during exercise, and may pave the way for therapeutic intervention focused on restoring mitochondrial fat-burning capacity.

1 January 2018 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
MMMichael P. Mohning
Michael P. Mohning
STStacey M. Thomas
Stacey M. Thomas
LBLea Barthel
Lea Barthel
KMKara J. Mould
Kara J. Mould
AMAlexandria L. McCubbrey
Alexandria L. McCubbrey
WJWilliam J. Janssen
William J. Janssen
Microparticles are a newly recognized class of mediators in the pathophysiology of lung inflammation and injury, but little is known about the factors that regulate their accumulation and clearance. The primary objective of our study was to determine whether alveolar macrophages engulf microparticles and to elucidate the mechanisms by which this occurs. Alveolar microparticles were quantified in bronchoalveolar fluid of mice with lung injury induced by LPS and hydrochloric acid. Microparticle numbers were greatest at the peak of inflammation and declined as inflammation resolved. Isolated, fluorescently labeled particles were placed in culture with macrophages to evaluate ingestion in the presence of endocytosis inhibitors. Ingestion was blocked with cytochalasin D and wortmannin, consistent with a phagocytic process. In separate experiments, mice were treated intratracheally with labeled microparticles, and their uptake was assessed though microscopy and flow cytometry. Resident alveolar macrophages, not recruited macrophages, were the primary cell-ingesting microparticles in the alveolus during lung injury. In vitro, microparticles promoted inflammatory signaling in LPS primed epithelial cells, signifying the importance of microparticle clearance in resolving lung injury. Microparticles were found to have phosphatidylserine exposed on their surfaces. Accordingly, we measured expression of phosphatidylserine receptors on macrophages and found high expression of MerTK and Axl in the resident macrophage population. Endocytosis of microparticles was markedly reduced in MerTK-deficient macrophages in vitro and in vivo. In conclusion, microparticles are released during acute lung injury and peak in number at the height of inflammation. Resident alveolar macrophages efficiently clear these microparticles through MerTK-mediated phagocytosis.

15 October 2020 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
MMMichael P. Mohning
Michael P. Mohning
IAIsabelle Amigues
Isabelle Amigues
MDM. Kristen Demoruelle
M. Kristen Demoruelle
EPEvans R Fernández Peréz
Evans R Fernández Peréz
THTristan J. Huie
Tristan J. Huie
JSJoshua J. Solomon
Joshua J. Solomon
Age of ILD onset is similar in patients with RA-UIP and RA-NSIP but duration of RA before ILD onset differshttps://bit.ly/3lgjfDJ

15 May 2019 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
EPEvans R Fernández Peréz
Evans R Fernández Peréz
DSDavid B. Sprunger
David B. Sprunger
PRPailin Ratanawatkul
Pailin Ratanawatkul
Lisa MaierLisa Maier
Lisa Maier
THTristan J. Huie
Tristan J. Huie
KBKevin K. Brown
Kevin K. Brown

5 April 2022 in JAMA
Verified
Journal Article
Open access
PDF file
EBEsther de Boer
Esther de Boer
IPIrina Petrache
Irina Petrache
MMMichael P. Mohning
Michael P. Mohning
A 33-year-old man with intermittent asthma presented with 3 months of dyspnea on exertion, which developed approximately 2 weeks after infection with SARS-CoV-2